ViThera Pharmaceuticals, Inc

ViThera uses live biotherapeutics to treat diseases of the GI tract. Our lead product is for Crohn's Disease and Ulcerative Colitis.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Cambridge, MA, USA
  • Currency USD
  • Employees 3
  • Website vitherapharma.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free